ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharma 4.0 Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-34T11198
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharma 4 0 Market Research Report 2022
BUY CHAPTERS

Global Pharma 4.0 Market Research Report 2025

Code: QYRE-Auto-34T11198
Report
January 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Abbott Laboratories
GE Healthcare
Boston Scientific
Medtronic Inc
Lonza Group AG
GlaxoSmithKline PLC
Koninklijke Philips N V
Glatt
Vertex
Johnson & Johnson
Goodly Innovations
QbDVision
Electrosan
GoSilico
Smart Factory
Körber AG

Pharma 4.0 Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharma 4.0 Market

Pharma 4.0 Market

The global market for Pharma 4.0 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pharma 4.0 is a holistic operating model for pharmaceutical factories and supply chains of the future based on Industry 4.0 capabilities, digital maturity, and data integrity by design.Pharma 4.0 is a framework for adapting digital strategies to the unique contexts of pharmaceutical manufacturing. In practical terms, it means more connectivity, more productivity, simplified compliance, and the marshaling of production information to respond to problems as they emerge.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharma 4.0, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma 4.0.
The Pharma 4.0 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma 4.0 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma 4.0 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharma 4.0 Market Report

Report Metric Details
Report Name Pharma 4.0 Market
CAGR 5%
Segment by Type
  • Cloud
  • On-premise
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc, Abbott Laboratories, GE Healthcare, Boston Scientific, Medtronic Plc., Lonza Group AG, GlaxoSmithKline plc., Koninklijke Philips N.V., Glatt GmbH, Vertex, Johnson & Johnson, Goodly Innovations, QbDVision, Electrosan, GoSilico, Smart Factory, Körber AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharma 4.0 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharma 4.0 Market report?

Ans: The main players in the Pharma 4.0 Market are Pfizer Inc, Abbott Laboratories, GE Healthcare, Boston Scientific, Medtronic Plc., Lonza Group AG, GlaxoSmithKline plc., Koninklijke Philips N.V., Glatt GmbH, Vertex, Johnson & Johnson, Goodly Innovations, QbDVision, Electrosan, GoSilico, Smart Factory, Körber AG

What are the Application segmentation covered in the Pharma 4.0 Market report?

Ans: The Applications covered in the Pharma 4.0 Market report are Pharmaceutical Industry, IoT Industry, Medical Equipment Industry, Others

What are the Type segmentation covered in the Pharma 4.0 Market report?

Ans: The Types covered in the Pharma 4.0 Market report are Cloud, On-premise

Recommended Reports

Pharmaceutical Markets

Pharma Digitalization

Pharma Operations

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma 4.0 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cloud
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Pharma 4.0 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Industry
1.3.3 IoT Industry
1.3.4 Medical Equipment Industry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma 4.0 Market Perspective (2020-2031)
2.2 Global Pharma 4.0 Growth Trends by Region
2.2.1 Global Pharma 4.0 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharma 4.0 Historic Market Size by Region (2020-2025)
2.2.3 Pharma 4.0 Forecasted Market Size by Region (2026-2031)
2.3 Pharma 4.0 Market Dynamics
2.3.1 Pharma 4.0 Industry Trends
2.3.2 Pharma 4.0 Market Drivers
2.3.3 Pharma 4.0 Market Challenges
2.3.4 Pharma 4.0 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma 4.0 Players by Revenue
3.1.1 Global Top Pharma 4.0 Players by Revenue (2020-2025)
3.1.2 Global Pharma 4.0 Revenue Market Share by Players (2020-2025)
3.2 Global Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharma 4.0 Revenue
3.4 Global Pharma 4.0 Market Concentration Ratio
3.4.1 Global Pharma 4.0 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma 4.0 Revenue in 2024
3.5 Global Key Players of Pharma 4.0 Head office and Area Served
3.6 Global Key Players of Pharma 4.0, Product and Application
3.7 Global Key Players of Pharma 4.0, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma 4.0 Breakdown Data by Type
4.1 Global Pharma 4.0 Historic Market Size by Type (2020-2025)
4.2 Global Pharma 4.0 Forecasted Market Size by Type (2026-2031)
5 Pharma 4.0 Breakdown Data by Application
5.1 Global Pharma 4.0 Historic Market Size by Application (2020-2025)
5.2 Global Pharma 4.0 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharma 4.0 Market Size (2020-2031)
6.2 North America Pharma 4.0 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharma 4.0 Market Size by Country (2020-2025)
6.4 North America Pharma 4.0 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharma 4.0 Market Size (2020-2031)
7.2 Europe Pharma 4.0 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharma 4.0 Market Size by Country (2020-2025)
7.4 Europe Pharma 4.0 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharma 4.0 Market Size (2020-2031)
8.2 Asia-Pacific Pharma 4.0 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharma 4.0 Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharma 4.0 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharma 4.0 Market Size (2020-2031)
9.2 Latin America Pharma 4.0 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharma 4.0 Market Size by Country (2020-2025)
9.4 Latin America Pharma 4.0 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma 4.0 Market Size (2020-2031)
10.2 Middle East & Africa Pharma 4.0 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharma 4.0 Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharma 4.0 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Details
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Pharma 4.0 Introduction
11.1.4 Pfizer Inc Revenue in Pharma 4.0 Business (2020-2025)
11.1.5 Pfizer Inc Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Pharma 4.0 Introduction
11.2.4 Abbott Laboratories Revenue in Pharma 4.0 Business (2020-2025)
11.2.5 Abbott Laboratories Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Pharma 4.0 Introduction
11.3.4 GE Healthcare Revenue in Pharma 4.0 Business (2020-2025)
11.3.5 GE Healthcare Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Details
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Pharma 4.0 Introduction
11.4.4 Boston Scientific Revenue in Pharma 4.0 Business (2020-2025)
11.4.5 Boston Scientific Recent Development
11.5 Medtronic Plc.
11.5.1 Medtronic Plc. Company Details
11.5.2 Medtronic Plc. Business Overview
11.5.3 Medtronic Plc. Pharma 4.0 Introduction
11.5.4 Medtronic Plc. Revenue in Pharma 4.0 Business (2020-2025)
11.5.5 Medtronic Plc. Recent Development
11.6 Lonza Group AG
11.6.1 Lonza Group AG Company Details
11.6.2 Lonza Group AG Business Overview
11.6.3 Lonza Group AG Pharma 4.0 Introduction
11.6.4 Lonza Group AG Revenue in Pharma 4.0 Business (2020-2025)
11.6.5 Lonza Group AG Recent Development
11.7 GlaxoSmithKline plc.
11.7.1 GlaxoSmithKline plc. Company Details
11.7.2 GlaxoSmithKline plc. Business Overview
11.7.3 GlaxoSmithKline plc. Pharma 4.0 Introduction
11.7.4 GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2020-2025)
11.7.5 GlaxoSmithKline plc. Recent Development
11.8 Koninklijke Philips N.V.
11.8.1 Koninklijke Philips N.V. Company Details
11.8.2 Koninklijke Philips N.V. Business Overview
11.8.3 Koninklijke Philips N.V. Pharma 4.0 Introduction
11.8.4 Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2020-2025)
11.8.5 Koninklijke Philips N.V. Recent Development
11.9 Glatt GmbH
11.9.1 Glatt GmbH Company Details
11.9.2 Glatt GmbH Business Overview
11.9.3 Glatt GmbH Pharma 4.0 Introduction
11.9.4 Glatt GmbH Revenue in Pharma 4.0 Business (2020-2025)
11.9.5 Glatt GmbH Recent Development
11.10 Vertex
11.10.1 Vertex Company Details
11.10.2 Vertex Business Overview
11.10.3 Vertex Pharma 4.0 Introduction
11.10.4 Vertex Revenue in Pharma 4.0 Business (2020-2025)
11.10.5 Vertex Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Pharma 4.0 Introduction
11.11.4 Johnson & Johnson Revenue in Pharma 4.0 Business (2020-2025)
11.11.5 Johnson & Johnson Recent Development
11.12 Goodly Innovations
11.12.1 Goodly Innovations Company Details
11.12.2 Goodly Innovations Business Overview
11.12.3 Goodly Innovations Pharma 4.0 Introduction
11.12.4 Goodly Innovations Revenue in Pharma 4.0 Business (2020-2025)
11.12.5 Goodly Innovations Recent Development
11.13 QbDVision
11.13.1 QbDVision Company Details
11.13.2 QbDVision Business Overview
11.13.3 QbDVision Pharma 4.0 Introduction
11.13.4 QbDVision Revenue in Pharma 4.0 Business (2020-2025)
11.13.5 QbDVision Recent Development
11.14 Electrosan
11.14.1 Electrosan Company Details
11.14.2 Electrosan Business Overview
11.14.3 Electrosan Pharma 4.0 Introduction
11.14.4 Electrosan Revenue in Pharma 4.0 Business (2020-2025)
11.14.5 Electrosan Recent Development
11.15 GoSilico
11.15.1 GoSilico Company Details
11.15.2 GoSilico Business Overview
11.15.3 GoSilico Pharma 4.0 Introduction
11.15.4 GoSilico Revenue in Pharma 4.0 Business (2020-2025)
11.15.5 GoSilico Recent Development
11.16 Smart Factory
11.16.1 Smart Factory Company Details
11.16.2 Smart Factory Business Overview
11.16.3 Smart Factory Pharma 4.0 Introduction
11.16.4 Smart Factory Revenue in Pharma 4.0 Business (2020-2025)
11.16.5 Smart Factory Recent Development
11.17 Körber AG
11.17.1 Körber AG Company Details
11.17.2 Körber AG Business Overview
11.17.3 Körber AG Pharma 4.0 Introduction
11.17.4 Körber AG Revenue in Pharma 4.0 Business (2020-2025)
11.17.5 Körber AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Abbott Laboratories
GE Healthcare
Boston Scientific
Medtronic Inc
Lonza Group AG
GlaxoSmithKline PLC
Koninklijke Philips N V
Glatt
Vertex
Johnson & Johnson
Goodly Innovations
QbDVision
Electrosan
GoSilico
Smart Factory
Körber AG
List of Tables
 Table 1. Global Pharma 4.0 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cloud
 Table 3. Key Players of On-premise
 Table 4. Global Pharma 4.0 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharma 4.0 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharma 4.0 Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharma 4.0 Market Share by Region (2020-2025)
 Table 8. Global Pharma 4.0 Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharma 4.0 Market Share by Region (2026-2031)
 Table 10. Pharma 4.0 Market Trends
 Table 11. Pharma 4.0 Market Drivers
 Table 12. Pharma 4.0 Market Challenges
 Table 13. Pharma 4.0 Market Restraints
 Table 14. Global Pharma 4.0 Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharma 4.0 Market Share by Players (2020-2025)
 Table 16. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2024)
 Table 17. Ranking of Global Top Pharma 4.0 Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharma 4.0 Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharma 4.0, Headquarters and Area Served
 Table 20. Global Key Players of Pharma 4.0, Product and Application
 Table 21. Global Key Players of Pharma 4.0, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharma 4.0 Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharma 4.0 Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharma 4.0 Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharma 4.0 Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharma 4.0 Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharma 4.0 Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharma 4.0 Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharma 4.0 Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharma 4.0 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharma 4.0 Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharma 4.0 Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharma 4.0 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharma 4.0 Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharma 4.0 Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharma 4.0 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharma 4.0 Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharma 4.0 Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharma 4.0 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharma 4.0 Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharma 4.0 Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharma 4.0 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharma 4.0 Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharma 4.0 Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pfizer Inc Company Details
 Table 47. Pfizer Inc Business Overview
 Table 48. Pfizer Inc Pharma 4.0 Product
 Table 49. Pfizer Inc Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 50. Pfizer Inc Recent Development
 Table 51. Abbott Laboratories Company Details
 Table 52. Abbott Laboratories Business Overview
 Table 53. Abbott Laboratories Pharma 4.0 Product
 Table 54. Abbott Laboratories Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 55. Abbott Laboratories Recent Development
 Table 56. GE Healthcare Company Details
 Table 57. GE Healthcare Business Overview
 Table 58. GE Healthcare Pharma 4.0 Product
 Table 59. GE Healthcare Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 60. GE Healthcare Recent Development
 Table 61. Boston Scientific Company Details
 Table 62. Boston Scientific Business Overview
 Table 63. Boston Scientific Pharma 4.0 Product
 Table 64. Boston Scientific Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 65. Boston Scientific Recent Development
 Table 66. Medtronic Plc. Company Details
 Table 67. Medtronic Plc. Business Overview
 Table 68. Medtronic Plc. Pharma 4.0 Product
 Table 69. Medtronic Plc. Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 70. Medtronic Plc. Recent Development
 Table 71. Lonza Group AG Company Details
 Table 72. Lonza Group AG Business Overview
 Table 73. Lonza Group AG Pharma 4.0 Product
 Table 74. Lonza Group AG Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 75. Lonza Group AG Recent Development
 Table 76. GlaxoSmithKline plc. Company Details
 Table 77. GlaxoSmithKline plc. Business Overview
 Table 78. GlaxoSmithKline plc. Pharma 4.0 Product
 Table 79. GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 80. GlaxoSmithKline plc. Recent Development
 Table 81. Koninklijke Philips N.V. Company Details
 Table 82. Koninklijke Philips N.V. Business Overview
 Table 83. Koninklijke Philips N.V. Pharma 4.0 Product
 Table 84. Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 85. Koninklijke Philips N.V. Recent Development
 Table 86. Glatt GmbH Company Details
 Table 87. Glatt GmbH Business Overview
 Table 88. Glatt GmbH Pharma 4.0 Product
 Table 89. Glatt GmbH Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 90. Glatt GmbH Recent Development
 Table 91. Vertex Company Details
 Table 92. Vertex Business Overview
 Table 93. Vertex Pharma 4.0 Product
 Table 94. Vertex Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 95. Vertex Recent Development
 Table 96. Johnson & Johnson Company Details
 Table 97. Johnson & Johnson Business Overview
 Table 98. Johnson & Johnson Pharma 4.0 Product
 Table 99. Johnson & Johnson Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 100. Johnson & Johnson Recent Development
 Table 101. Goodly Innovations Company Details
 Table 102. Goodly Innovations Business Overview
 Table 103. Goodly Innovations Pharma 4.0 Product
 Table 104. Goodly Innovations Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 105. Goodly Innovations Recent Development
 Table 106. QbDVision Company Details
 Table 107. QbDVision Business Overview
 Table 108. QbDVision Pharma 4.0 Product
 Table 109. QbDVision Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 110. QbDVision Recent Development
 Table 111. Electrosan Company Details
 Table 112. Electrosan Business Overview
 Table 113. Electrosan Pharma 4.0 Product
 Table 114. Electrosan Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 115. Electrosan Recent Development
 Table 116. GoSilico Company Details
 Table 117. GoSilico Business Overview
 Table 118. GoSilico Pharma 4.0 Product
 Table 119. GoSilico Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 120. GoSilico Recent Development
 Table 121. Smart Factory Company Details
 Table 122. Smart Factory Business Overview
 Table 123. Smart Factory Pharma 4.0 Product
 Table 124. Smart Factory Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 125. Smart Factory Recent Development
 Table 126. Körber AG Company Details
 Table 127. Körber AG Business Overview
 Table 128. Körber AG Pharma 4.0 Product
 Table 129. Körber AG Revenue in Pharma 4.0 Business (2020-2025) & (US$ Million)
 Table 130. Körber AG Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Pharma 4.0 Picture
 Figure 2. Global Pharma 4.0 Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharma 4.0 Market Share by Type: 2024 VS 2031
 Figure 4. Cloud Features
 Figure 5. On-premise Features
 Figure 6. Global Pharma 4.0 Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharma 4.0 Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical Industry Case Studies
 Figure 9. IoT Industry Case Studies
 Figure 10. Medical Equipment Industry Case Studies
 Figure 11. Others Case Studies
 Figure 12. Pharma 4.0 Report Years Considered
 Figure 13. Global Pharma 4.0 Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pharma 4.0 Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pharma 4.0 Market Share by Region: 2024 VS 2031
 Figure 16. Global Pharma 4.0 Market Share by Players in 2024
 Figure 17. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pharma 4.0 Revenue in 2024
 Figure 19. North America Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pharma 4.0 Market Share by Country (2020-2031)
 Figure 21. United States Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharma 4.0 Market Share by Country (2020-2031)
 Figure 25. Germany Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharma 4.0 Market Share by Region (2020-2031)
 Figure 33. China Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharma 4.0 Market Share by Country (2020-2031)
 Figure 41. Mexico Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharma 4.0 Market Share by Country (2020-2031)
 Figure 45. Turkey Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pharma 4.0 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer Inc Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 49. Abbott Laboratories Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 50. GE Healthcare Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 51. Boston Scientific Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 52. Medtronic Plc. Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 53. Lonza Group AG Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 54. GlaxoSmithKline plc. Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 55. Koninklijke Philips N.V. Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 56. Glatt GmbH Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 57. Vertex Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 58. Johnson & Johnson Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 59. Goodly Innovations Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 60. QbDVision Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 61. Electrosan Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 62. GoSilico Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 63. Smart Factory Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 64. Körber AG Revenue Growth Rate in Pharma 4.0 Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Pharma E Commerce Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharma Analytics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharma Contract Service Market Research Report 2025
Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmerging Market Research Report 2025
Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024
Global Pharmaceutical Blockchain Market Research Report 2024
Global Pharmaceutical Asset Management Market Research Report 2025
Global Blockchain in Pharmaceutical Supply Chain Market Research Report 2025
Digital Pharma Knowledge Management Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Asset Managements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digital Pharma Solution Market Research Report 2025
Global Chemistry 4 0 Market Research Report 2025
Global Pharma Cosmetics Market Insights Forecast to 2030
Pharma Tubing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Marketing Digital Platform Market Research Report 2024
Global Treatment Planning Software Market Research Report 2025
Global Pharmaceutical E commerce Market Research Report 2024
Global Diagnostic Guidewire Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions